Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer

International Journal of Radiation Oncology Biology Physics

Volumn 59, Issue 1, 2004, Pages 67-71

  Koukourakis, Michael I ^a,d   Giatromanolaki, Alexandra ^a   Sivridis, Efthimios ^a   Pastorek, Jaromir ^b   Karapantzos, Ilias ^a   Gatter, Kevin C ^c   Harris, Adrian L ^c  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b INSTITUTE OF VIROLOGY   (Slovakia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d Tumor and Angiogenesis Research Group Alexandroupolis   (Greece)

Author keywords

Anemia; Differentiated embryo chondrocyte protein; Head and neck cancer; Hypoxia inducible factor , Carbonic anhydrase 9

Indexed keywords

BLOOD; HEMOGLOBIN; OXYGEN; PATHOLOGY; PATIENT MONITORING; PH EFFECTS; SENSITIVITY ANALYSIS; TUMORS;

BLOOD FLOW; MICROVESSELS; TUMOR PATHWAYS; TUMOR-RELATED GENE;

ONCOLOGY;

CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE IX; DIFFERENTIATED EMBRYO CHONDROCYTE PROTEIN; HEMOGLOBIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 2ALPHA; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANEMIA; ANGIOGENESIS; ARTICLE; BLOOD OXYGENATION; CANCER RADIOTHERAPY; CONTROLLED STUDY; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOXIA; OXYGEN CONSUMPTION; PH; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

ANEMIA; CARBONIC ANHYDRASES; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; DNA-BINDING PROTEINS; HEAD AND NECK NEOPLASMS; HEMOGLOBINS; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXIA-INDUCIBLE FACTOR 1; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; NUCLEAR PROTEINS; PROTEINS; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 10444271234     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2003.10.016     Document Type: Article

References (33)

1. Kumar P. Tumour hypoxia and anemia Impact on the efficacy of radiation therapy. Semin Hematol. 37:(Suppl. 6):2000;4-8.
2. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Cancer vascularization Implications in radiotherapy? Int J Radiat Oncol Biol Phys. 48:2000;545-553.
3. 2 homeostasis. Curr Opin Genet Develop. 8:1998;588-594.
4. Harris A.L. Hypoxia A key regulatory factor in tumour growth. Nat Rev Cancer. 2:2002;38-47.
5. Talks K.L., Turley H., Gatter K.C., et al. The expression and distribution of the hypoxia inducible factors HIF-1α and HIF-2α in normal human tissues, cancers and tumor associated macrophages. Am J Pathol. 157:2000;2411-2421.
6. Pastorek P., Pastorekova S., Callebaut I., et al. Cloning and characterization of MN, a human tumor-associated protein with a domain homologous to carbonic anhydrase and a putative helix-loop-helix DNA binding segment. Oncogene. 9:1994;2877-2888.
7. Pastorekova S., Zavadova Z., Kostal M., et al. A novel quasi-viral agent, MaTu, is a two-component system. Virology. 187:1992;620-626.
8. Vukovic V., Haugland H.K., Nicklee T., et al. Hypoxia-inducible factor-1alpha is an intrinsic marker for hypoxia in cervical cancer xenografts. Cancer Res. 61:2001;7394-7398.
9. Loncaster J.A., Harris A.L., Davidson S.E., et al. Carbonic anhydrase (CA IX) expression, a potential new intrinsic marker of hypoxia Correlations with tumour oxygen measurements and prognosis in locally advanced carcinoma of the cervix. Cancer Res. 61:2001;6394-6399.
10. Wykoff C.C., Pugh C.W., Maxwell P.H., et al. Identification of novel hypoxia dependent and independent target genes of the von Hippel Lindau (VHL) tumor suppressor by mRNA differential expression profiling. Oncogene. 19:2000;6297-6305.
11. Giatromanolaki A., Koukourakis M.I., Turley H., et al. DEC1 (STRA13) protein expression relates to hypoxia inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol. 200:2003;222-228.
12. Brown N.S., Jones A., Fujiyama C., et al. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. Cancer Res. 60:2000;6298-6302.
13. Dische S. Radiotherapy and anaemia - The clinical experience. Radiother Oncol. 20:(Suppl.):1991;35-40.
14. Giatromanolaki A., Koukourakis M.I., Georgoulias V., et al. Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer. Int J Cancer. 80:1999;810-817.
15. Giatromanolaki A., Koukourakis M.I., Sivridis E., et al. Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas. Clin Exp Metastasis. 18:2000;313-319.
16. Koukourakis M.I., Giatromanolaki A., Fountzilas G., et al. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy. Clin Cancer Res. 6:2000;381-389.
17. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer. Int J Radiat Oncol Biol Phys. 53:2002;1192-1202.
18. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy. Clin Cancer Res. 7:2001;3399-3403.
19. Cooper R.A., Wilks D.P., Logue J.P., et al. High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy. Clin Cancer Res. 4:1998;2795-2800.
20. Aebersold D.M., Burri P., Beer K.T., et al. Expression of hypoxia-inducible factor-1alpha A novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res. 61:2001;2911-2916.
21. Koukourakis M.I., Giatromanolaki A., Skarlatos J., et al. Hypoxia k(HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 61:2001;1830-1832.
22. Hui E.P., Chan A.T., Pezzella F., et al. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin Cancer Res. 8:2002;2595-2604.
23. Rapisarda A., Uranchimeg B., Scudiero D.A., et al. Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway. Cancer Res. 62:2002;4316-4324.
24. Maxwell P.H., Wiesener M.S., Chang G.W., et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 399:1999;271-275.
25. Mazure N.M., Chen E.Y., Laderoute K.R., et al. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidylinositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood. 90:1999;3322-3331.
26. Hudson C.C., Liu M., Chiang G.G., et al. Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol Cell Biol. 22:2002;7004-7014.
27. Zhong H., Chiles K., Feldser D., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells Implications for tumor angiogenesis and therapeutics. Cancer Res. 60:2000;1541-1545.
28. Lee D.J., Cosmatos D., Marcial V.A. Results of an RTOG phase III trial (RTOG 85-27) comparing radiotherapy plus etanidazole with radiotherapy alone for locally advanced head and neck carcinomas. Int J Radiat Oncol Biol Phys. 32:1995;567-576.
29. Dische S. What have we learnt from hyperbaric oxygen? Radiother Oncol. 20:(Suppl. 1):1991;71-74.
30. Koukourakis M.I., Giatromanolaki A., Sivridis E., et al. Squamous cell head and neck cancer Evidence of angiogenic regeneration during radiotherapy. Anticancer Res. 21:2001;4301-4309.
31. Akakura N., Kobayashi M., Horiuchi I., et al. Constitutive expression of hypoxia-inducible factor-1alpha renders pancreatic cancer cells resistant to apoptosis induced by hypoxia and nutrient deprivation. Cancer Res. 61:2001;6548-6554.
32. Gorski D.H., Beckett M.A., Jaskowiak N.T., et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 59:1999;3374-3378.
33. Brizel D.M., Schroeder T., Scher R.L., et al. Elevated tumor lactate concentrations predict for an increased risk of metastases in head-and-neck cancer. Int J Radiat Oncol Biol Phys. 51:2001;349-353.